Analysis of the Worldwide Liquid Biopsy Market to 2028: Rising Preference For Minimally Invasive Form Of Cancer Diagnostics – PRNewswire

Share Article

Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Dec 24, 2021, 14:45 ET
Share this article
DUBLIN, Dec. 24, 2021 /PRNewswire/ — The "Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, CTC), By Technology (NGS, PCR Microarrays), By Sample Type, By Region (APAC, North America), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com’s offering.
The global liquid biopsy market size is expected to reach USD 19.35 billion by 2028, registering a CAGR of 13.5% during the forecast period. It is a revolutionary technique that has created various opportunities that were previously unexplored.
It aids in the detection and isolation of circulating tumor DNA, exosomes, and circulating tumor cells and is a source of proteomics and genomics information in cancer patients.
Rapid development in digital Polymerase Chain Reaction (PCR) and NGS-based technology has improved the accuracy of liquid biopsy. It can be performed repeatedly for disease monitoring and is anticipated to help overcome the limitations of tissue biopsies.

As liquid biopsies are the most promising novel techniques for cancer care, established as well as emerging companies have increased their R&D to develop novel liquid biopsy solutions.
Liquid Biopsy Market Report Highlights
Key Topics Covered
Industry Outlook
Market Dynamics
Technology Business Analysis
Sample Type Business Analysis
Biomarker Business Analysis
Regional Business Analysis
Competitive Landscape
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/lt8c1j
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets
http://www.researchandmarkets.com

More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness